Barrett Hodgson Pakistan (Pvt) Ltd launches BariMox Tablet which contains Moxifloxacin – 4th generation flouroquinolone.
BariMox offers the effective treatment of Acute Sinusitis, Acute Exacer-bation of Chronic Bronchitis, Community Acquired Pneumonia, MDRSP (Multi-Drug Resistant Strepto-coccus Pneumonia), Compli-cated & Un-complicated Skin and Skin Structure Infections & Complicated Intra-Abdominal Infections.
BariMox is available as tablet in pack of 5’s.
By introducing BariMox (Moxifloxacin), Barrett Hodgson has provided another Effective, yet Economical and Quality product for the ailing humanity.